The Goldman Sachs Group, Inc. 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-07 6:08 pm Sale |
2022-12-30 | 13G | Addex Therapeutics Ltd ADXN |
GOLDMAN SACHS GROUP INC GS |
103 0.000% |
-150,246 (-99.93%) |
Filing |
| 2022-02-14 3:32 pm Purchase |
2021-12-31 | 13G | Addex Therapeutics Ltd ADXN |
GOLDMAN SACHS GROUP INC GS |
150,349 6.100% |
150,349 (New Position) |
Filing |